Aker BioMarine AS (OSL:AKBM)

Aker BioMarine AS Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,911	5,884	4,033	3,335	4,756	10,291
Market Cap Growth	45.89%	45.89%	20.94%	-29.89%	-53.79%	-
Enterprise Value	6,417	7,308	8,170	7,246	7,421	12,373
Last Close Price	56.00	67.10	25.59	21.16	30.20	65.36
PE Ratio	2.38	2.85	-	33.85	-	-
Forward PE	89.30	179.33	80.58	30.13	-	26.43
PS Ratio	2.60	2.60	1.19	1.22	2.06	4.16
PB Ratio	2.98	2.98	1.09	0.89	1.46	3.22
P/TBV Ratio	7.44	7.44	1.85	1.54	2.68	6.23
P/FCF Ratio	-	265.14	-	-	-
P/OCF Ratio	42.45	42.45	8.39	22.42	207.63	-
EV/Sales Ratio	2.84	3.23	2.40	2.65	3.21	5.00
EV/EBITDA Ratio	14.75	16.80	16.15	12.04	21.88	29.02
EV/EBIT Ratio	-	138.91	45.12	-	165.60
EV/FCF Ratio	-68.88	-	537.11	-	-	-
Debt / Equity Ratio	0.85	0.85	1.07	1.01	0.88	0.65
Debt / EBITDA Ratio	3.85	3.85	7.20	5.82	7.37	4.33
Debt / FCF Ratio	-	-	262.00	-	-	-
Asset Turnover	0.33	0.33	0.41	0.35	0.36	0.41
Inventory Turnover	0.93	0.93	1.17	0.97	1.38	1.68
Quick Ratio	1.30	1.30	0.83	0.84	0.93	1.05
Current Ratio	3.79	3.79	2.57	2.85	3.10	3.15
Return on Equity (ROE)	-5.29%	-5.29%	-2.42%	2.67%	-2.15%	-2.07%
Return on Assets (ROA)	-0.68%	-0.68%	0.44%	1.29%	-0.59%	0.78%
Return on Capital (ROIC)	-0.76%	-0.76%	0.48%	1.40%	-0.66%	0.92%
Return on Capital Employed (ROCE)	-	-	0.80%	2.30%	-	1.40%
Earnings Yield	41.98%	35.05%	-2.26%	2.95%	-1.48%	-0.46%
FCF Yield	-1.90%	-1.58%	0.38%	-7.50%	-14.10%	-6.05%
Payout Ratio	205.62%	205.62%	-	-	-	-
Buyback Yield / Dilution	-	-0.04%	-0.05%	-12.20%	-13.05%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.